We've found
644
archived clinical trials in
Dental
We've found
644
archived clinical trials in
Dental
Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants
Updated: 12/31/1969
A Retrospective Multicenter Study Evaluating ATLANTIS™ Abutments on Implants From Four Manufacturers
Status: Enrolling
Updated: 12/31/1969
Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants
Updated: 12/31/1969
A Retrospective Multicenter Study Evaluating ATLANTIS™ Abutments on Implants From Four Manufacturers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Updated: 12/31/1969
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Status: Enrolling
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Status: Enrolling
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Updated: 12/31/1969
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Updated: 12/31/1969
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Status: Enrolling
Updated: 12/31/1969
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Updated: 12/31/1969
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Updated: 12/31/1969
An Open-Label, Proof of Concept, Efficacy, Safety and Tolerability Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy
Status: Enrolling
Updated: 12/31/1969
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Updated: 12/31/1969
An Open-Label, Proof of Concept, Efficacy, Safety and Tolerability Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Emdogain Minimally Invasive Surgical Technique
Updated: 12/31/1969
Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Updated: 12/31/1969
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Updated: 12/31/1969
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV
Updated: 12/31/1969
Preliminary Phase IV Trial Comparing the SOVA Night Guard With the Clinical Standard Acrylic Orthotic
Status: Enrolling
Updated: 12/31/1969
Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV
Updated: 12/31/1969
Preliminary Phase IV Trial Comparing the SOVA Night Guard With the Clinical Standard Acrylic Orthotic
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials